Drug class
Barbiturate antiseizure medicine; phenobarbital derivative
Mechanism of action
Metabolised in part to phenobarbital and enhances GABA-mediated inhibition by prolonging opening of GABAA receptor-associated chloride channels at higher concentrations, reducing neuronal excitability.
General use cases
- Historically used for treatment of selected epileptic seizure types, including tonic-clonic and focal seizures, in jurisdictions where methylphenobarbital products remain authorised; current availability is limited
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
